The trabecular bypass stent in a pseudophakic glaucoma patient: A 1-year follow-up

Figures & data

Table 1 Clinical characteristics at baseline

Medical history	Asthma
	NIDDM
Previous surgery	Pace maker implantation (2000)
	LE cataract surgery (2003)
Glaucoma therapy	OU: dorzolamide tid
	RE: Brimonidine bid
	Acetazolamide 250 mg ½ tablet tid
IOP	RE: 19 mm Hg
	LE: 10 mm Hg
Central corneal thickness	RE: 535
	LE: 543

Figure 1 The stent is seen correctly placed at the trabecular meshwork level.

Figure 2 Left: The gonioscopic view of the stent. Right: The UBM shows the hyperechogenic structure of the stent (circle), placed below the corneal wedge (arrow).